FindTrial
Sign In

A study on drug-drug interactions in patients with chronic kidney disease

A Study on Potential Drug-Drug Interactions among Patients with Chronic Kidney Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098280
Enrollment
217
Registered
2025-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NITTE (Deemed to be University),NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged above 18 years, diagnosed with CKD and have received treatment. Patient prescribed with more than one drug.

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records. Critically ill patients.

Design outcomes

Primary

MeasureTime frame
The study will help to identify and assess the prevalence and severity of drug-drug interactions among chronic kidney disease patients.Timepoint: At baseline—

Secondary

MeasureTime frame
The Study will evaluate the association between the number of drugs prescribed and the risk of drug-drug interactionsTimepoint: One year—

Countries

India

Contacts

Public ContactDr Nandakumar UP

NGSM Institute of Pharmaceutical Sciences

nandakumar@nitte.edu.in9633023062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026